Molecular imaging study on in vivo distribution and pharmacokinetics of modified small interfering RNAs (siRNAs)

Oligonucleotides
Thomas VielBertrand Tavitian

Abstract

Molecular imaging was used to study the biodistribution, pharmacokinetics, and activity of naked small interfering RNAs (siRNAs). siRNAs with riboses chemically modified in the 2' position were compared with unmodified siRNA. In vitro, replacement of the 2'-hydroxyl (2'OH) group of certain nucleotides in an siRNA sequence by a fluorine atom (2'F) on both antisense (AS) and sense (S) strands [2'F(AS/S)], or by a methoxy group (2'OMe) on the S strand [2'OH(AS)/2'OMe(S)], was compatible with RNA interference. Different siRNAs [2'F(AS/S), 2'OH(AS)/2'OMe(S), and 2'OH(AS/S)] were labeled with fluorine-18 (conjugation with [(18)F]FPyBrA), and comparative dynamic and quantitative imaging was performed with positron emission tomography. After intravenous injections of [(18)F]siRNAs in rodents, total radioactivity was rapidly eliminated by the kidneys and the liver. Tissue distribution of the different siRNAs were similar, and their bioavailability (as judged from blood persistence and stability) increased in the order 2'OH(AS/S) = 2'OH(AS)/2'OMe(S) < 2'F(AS/S). However, in our in vivo model, the 2'F(AS/S) siRNA, despite its higher bioavailability, was not able to induce a higher interference effect with respect to the 2'OH(AS/S) siRNA. ...Continue Reading

References

Jan 1, 1995·Clinical Pharmacokinetics·S AgrawalJ Tang
Apr 18, 1998·Nature Medicine·B TavitianL Di Giamberardino
Jan 16, 2003·Nucleic Acids Research·Mohammed AmarzguiouiHans Prydz
Feb 26, 2003·Genes & Development·John G DoenchPhillip A Sharp
Mar 26, 2003·Journal of Molecular Biology·Dag R SørensenMouldy Sioud
May 20, 2003·Nature Biotechnology·Aimee L JacksonPeter S Linsley
May 29, 2003·Nucleic Acids Research·Frank CzaudernaJörg Kaufmann
Aug 19, 2003·RNA·Ya-Lin Chiu, Tariq M Rana
Aug 28, 2003·Nature Cell Biology·Carol A SledzBryan R G Williams
Feb 26, 2004·Bioorganic & Medicinal Chemistry Letters·Dwaine A BraaschDavid R Corey
Apr 22, 2004·RNA·Juliana M LayzerBruce A Sullenger
May 29, 2004·Trends in Pharmacological Sciences·Adriana MaggiPaolo Ciana
Jul 24, 2004·Nucleic Acids Research·Dimitri SemizarovStephen Fesik
Sep 24, 2004·Annals of Surgery·Mark S DuxburyEdward E Whang
Oct 29, 2004·Nucleic Acids Research·Kathrin S SchmidtVolker A Erdmann
Nov 13, 2004·Nature·Jürgen SoutschekHans-Peter Vornlocher
Nov 24, 2004·Current Opinion in Chemical Biology·Muthiah Manoharan
Dec 8, 2004·Current Drug Targets·Adriano Duatti
Mar 5, 2005·Nature Medicine·Marjorie A Robbins, John J Rossi
Jun 25, 2005·Journal of Medicinal Chemistry·Thazha P PrakashBalkrishen Bhat
Aug 24, 2005·FEBS Letters·Susan L Uprichard
Dec 13, 2005·Clinical Science·Daniel CejkaVolker Wacheck
Dec 14, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Adam D JudgeIan MacLachlan
Feb 10, 2006·Biomolecular Engineering·Andrei L Gartel, Eugene S Kandel
Feb 16, 2006·Drug Discovery Today·Frank Y XiePatrick Y Lu
Feb 17, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mark A Behlke
Mar 28, 2006·Nature·Tracy S ZimmermannIan MacLachlan
May 23, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Femke M van de WaterRosalinde Masereeuw
Sep 6, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·N ToubP Couvreur
Feb 27, 2007·Nature Medicine·Zdravka MedarovaAnna Moore
Sep 18, 2007·Nature Biotechnology·Christian WolfrumMarkus Stoffel
Sep 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Derek W BartlettMark E Davis

❮ Previous
Next ❯

Citations

Apr 30, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shan GaoJørgen Kjems
Dec 22, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Garrett R Rettig, Mark A Behlke
Jan 16, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Thomas VielAndreas H Jacobs
Feb 26, 2010·Nucleosides, Nucleotides & Nucleic Acids·James A H InksterThomas J Ruth
Nov 26, 2008·Oligonucleotides·Mark A Behlke
Dec 25, 2010·Nucleic Acids Research·Pradeep S PallanMartin Egli
Mar 20, 2009·The AAPS Journal·Bo YuRobert J Lee
Oct 6, 2012·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Tomohiro Asai
Dec 5, 2012·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hidenori AndoNaoto Oku
Jan 19, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Hao HongWeibo Cai
Jan 10, 2016·Nuclear Medicine and Biology·Marlies GijsAndré Luxen
Feb 26, 2011·Angewandte Chemie·Muthiah ManoharanMartin Egli
Jan 10, 2012·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Marytheresa A Ifediba, Anna Moore
Aug 12, 2009·Basic & Clinical Pharmacology & Toxicology·Jun Li, Zicai Liang
Apr 9, 2017·Pharmaceutical Research·Ricardo Titze-de-AlmeidaSimoneide Souza Titze-de-Almeida
Oct 30, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tim EfthymiouJean-Paul Desaulniers
Mar 26, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jesper ChristensenPiet Swart
Jan 29, 2016·The Journal of Biological Chemistry·Pyoung Oh YoonChun Geun Lee
May 21, 2019·Frontiers in Pharmacology·Ivan V ChernikovElena L Chernolovskaya
Aug 6, 2020·Circulation Research·Xiaowei NieJin-Song Bian
Jul 5, 2017·Chemical & Pharmaceutical Bulletin·Shintaro Fumoto, Koyo Nishida
Dec 23, 2010·Bioconjugate Chemistry·Frédéric MercierAndré Luxen
Mar 17, 2010·Advanced Drug Delivery Reviews·Peixuan GuoYi Shu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.